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Available online 5 May 2016Wegener's granulomatosis (granulomatosis with polyangiitis) is a form of vasculitis of small-to-medium-sized
vessels and associated with diffuse anti-neutrophil cytoplasmic antibodies (cANCA). Cardiac involvement is
not uncommon with 6–25% of unselected patients and up to 44% of patients with severe renal involvement.
We report a 23-year-old man with Wegener's cardiomyopathy with 25% ejection fraction. The overall mortality
rate ofWegener's granulomatosis with cardiac involvement has been reported to be between 15 and 45%. So it is
important to keep in mind that cardiac examination is a must to detect if cardiac involvement is present.
© 2016 The Society of Cardiovascular Academy. Production and hosting by Elsevier B.V. All rights reserved. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Wegener's granulomatosis (granulomatosis with polyangiitis) is a
form of vasculitis of small-to-medium-sized vessels and associated
with diffuse anti-neutrophil cytoplasmic antibodies (cANCA). It typical-
ly affects the upper and lower airways, lungs, and kidneys. Cardiac in-
volvement is not uncommon with 6–25% of unselected patients and
up to 44% of patients with severe renal involvement. It usually presents
as pericarditis, myocarditis, and aortitis, although conduction distur-
bances and myocardial infarction are also recognised (1). Cardiac
manifestations are often not clinically apparent, but are associated
with increased morbidity and mortality (2). We report a case of
Wegener's cardiomyopathy with renal involvement.
Case presentation
A 23-year-old man presented with 1 month history of paroxysmal
nocturnal dsypnoea, fatigue, fevers, and joint pains. On examination,
he was tachypnoeic with a respiratory rate of 26/min and had a tachy-
cardia of 116/min. He was normotensive. Auscultation of his heart re-
vealed a gallop rhythm and crackles were heard throughout both lung
ﬁelds. The initial diagnostic workup involved a complete blood count,
urine analysis, electrocardiogram (ECG), and chest x-ray. Abnormal
laboratory ﬁndings were as follows: creatinine level was 2.7 mg/dl, po-
tassium level was 5.9 mmol/L, serum sodium level was 129 mmol/L. He
had hematuria and proteinuria, ECG revealed sinus tachycardia
with 118 beats per minute. Chest x-ray revealed extensive bilateral
interstitial pulmonary inﬁltrates, small bilateral pleural effusions, anddiovascular Academy.
y. Production and hosting by Elsevcardiomegaly. Due to elevated serum creatinine levels and hematuria,
patient evaluated by nephrologist. After a detailed examination, with
his physical ﬁndings, blood counts (levels of ESR, CRP, cANCA) were
high, initial diagnosiswas vasculitis, especiallyWegener's granulomato-
sis. Renal biopsy was performed and the result was compatible with
Wegener's granulomatosis (Fig. 1). Transthorasic echocardiography
was performed and revealed severely reduced left ventricular ejection
fraction (EF) estimated around 25%. Haemodialysis was performed. To
determine if conduction pathway involvement was present or not,
Holter ECG was recorded, and no rhythm problem was established.Fig 1.
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Fig. 2. Transesophageal echocardiography of the patient.
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cept trivial aortic regurgitation (Figs. 2,3).
Cardiac MRI that was performed for myocarditis revealed dilated
ventricules; late gadolinium enhancement (LGE) lesions involving LV
myocardium and LGE lesions were found in subepicardial, midwall,
and subendocardial LV myocardial layers, LVEF %24.
We recommend coronary angiography but he refused it.
He was treated with furosemid, cyclophosphamide, and prostacy-
clin. He admitted to routine haemodialysis programme. After 1 month
of follow-up, transthoracic echocardiography was performed again but
no cardiac remission obtained. Medication continued for 3 months
and then for the depressed systolic functions of left ventricle echocardi-
ography repeated but no changes revealed. At the end of 6 months of
follow-up period, his LVEF is the same as diagnosis period.
Discussion
Cardiac involvement ofWegeners's granulomatosis was ﬁrst report-
ed byWegener in 1936 (3). Classical or generalisedWG is characterised
by necrotising granulomatous vasculitis of the upper and lowerFig. 3. Transesophageal echocarespiratory tract together with glomerulonephritis. Widespread dis-
seminated vasculitis involving both small arteries and veins occurs to
a greater or lesser degree as the disease progresses. A localised form of
WG limited primarily to the upper and lower respiratory tracts has
been described (4,5). Despite histopathological diagnosis of WG, with
autoantibodies against to circulatory neutrophilic cytoplasmic antigens,
we can diagnose WG easily and early. WGmust be kept in mind as the
differential diagnosis of dilated cardiomyopathy, especially in the exis-
tence of pulmonary and renal pathologies. The clinical presentation of
WG can be so diverse that the list of differential diagnoses is vast,
ranging from infections (fungal, bacterial, and mycobacterial) to other
vasculitides, including Henoch–Schönlein purpura, sarcoidosis, Behcet
syndrome, and malignancies(6). Table 1 shows signs and symptoms
and systemic involvement of WG (6,7). Despite that involving the
heart is well described, signiﬁcant cardiac complications occurring
during the course of the disease are rare (7). Pericarditis is the most
common cardiac manifestation accounting for about 50% of cardiac
diseases in Wegener's granulomatosis, which is asymptomatic in most
of the cases, or may be manifested by chest pain and dyspnoea (8,9).
The overall mortality rate of Wegener's granulomatosis with cardiacrdiography of the patient.
Table 2
Cardiac manifestations in Wegener's granulomatosis.
-Pericarditis -Conduction abnormalities
-Coronary arteritis -Myocarditis
-Myocardial ischemia -Noninfectious endocarditis
-Valvular regurgitation–stenosis -Heart failure
Table 1
Signs and symptoms and systemic involvement of WG.
Signs and symptoms % Systemic involvement
Rhinorrhea and sinus pain 94 100 Respiratory tract
Fever 78 83 Renal
Anorexia and weight loss 78 56 Joints
Cough 61 44 Skin or muscle
Chest pain 56 39 Eye
Arthralgia 56 39 Middle ear
Skin lesions 44 28 Heart or pericardium
Otitis media 39 22 Nervous system
Eye symptoms 39
Hemoptysis 22
Arthritis 22
Neurological symptoms 22
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manifestations are presented in Table 2 (11,12).
In summary, Wegener's granulomatosis not infrequently affects the
heart, particularly inmore advanced cases of the disease, andmay causeclinically important complications. Pathologically, pericarditis, and
coronary arteritis are the commonest manifestations. Clinically, evi-
dence of pericarditis and its complications as well as supraventricular
arrhythmias and varying degrees of heart block are the most common
features. The advent of cANCA monitoring and the beneﬁts of modem
therapeutic approaches have resulted in many long-term survivors
with previously severeWegener's granulomatosis. Such patients not in-
frequently relapse with atypical presentations and cardiac involvement
may therefore be seen more often in the future.
